Candela to Introduce a Breakthrough Wrinkle Reduction Laser At Japanese Symposium.

Business/Techology Editors and Health Writers

TOKYO--(BW HealthWire)--Jan. 17, 2001

Distinguished Laser Physicians Will Discuss Efficacy of New Diode

Laser For Reducing Fine Lines and Wrinkles

Candela Corporation (NASDAQ:CLZR) announced today that it's wholly owned Japanese subsidiary Candela KK will launch its new Smoothbeam(TM) diode laser at a special symposium on January 28, at Tokyo's Hotel Kokusai Kanko. The symposium is to introduce the breakthrough Smoothbeam skin renewal laser, whose unique 1450 nm diode-based technology leads to smoother skin and fewer wrinkles, to an elite group of several hundred Japanese physicians, spa practitioners and clinicians.

The chief presenter will be David J. Goldberg, MD, Chief of Dermatologic Sugery at the New Jersey Medical School and Director of Skin Laser and Surgery Specialists of New York and New Jersey. Also making presentations will be Dr. Toshitatsu Nogita, Director of the Tokyo Yaese Clinic; Dr. Atsuko Mizuno, Director of the Skin Clinic Daikanyama; and Dr. Satoshi Nomura, a plastic and reconstruction surgeon affiliated with Tokyo Keisatsu Hospital.

Dr. David Goldberg comments about the Smoothbeam, "This new laser uses a unique combination of optimum wavelength and skin cooling protection to take skin renewal to new levels of efficacy, safety, comfort and ease of use. In addition, the laser is being offered at a price that makes it affordable to all sizes of practice."

The new Smoothbeam laser offers practitioners an unprecedented package of benefits:

--Highly Portable and Convenient: Weighing less than 40 pounds, Smoothbeam is a tabletop unit - simple to use and operate, easy to transport and store.

--Affordably Priced: Smoothbeam's breakthrough pricing makes it an attractive investment for physicians interested in offering skin renewal services to their patients.

--New Technology: Not a rejuvenation product, Smoothbeam's LASR(TM) (laser assisted skin renewal) process is a completely new technology for collagen remodeling. The unique 1450 nm wavelength selectively heats the upper dermis, inducing a mild thermal injury. The body's natural healing response initiates collagen remodeling and the deposition of new, organized collagen. The result is smoother, more uniform skin.

--Protects the Epidermis: Smoothbeam features Candela's patented Dynamic Cooling Device (DCD)(TM), which cools the epidermis prior to and during laser exposure. DCD automates the delivery of cryogen to optimally control the thermal injury so heating can occur at desired penetration depth while surrounding areas remain cool. Thus, skin renewal is achieved effectively.

--Minimal Patient Downtime: Effective skin protection means that patients experience minimal downtime when compared to conventional treatments. No pre-treatment or post-treatment care means that anatomic treatments around eyes and upper lip can be given quickly and easily.

For more about Candela's breakthrough Smoothbeam diode laser, including interviews and scientific information, call Jane Smith at 800-733-8550, x 247.

About Candela: Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 50 countries from offices in the United States, Europe, Japan and Asia. Candela established the aesthetic laser market 12 years ago, and currently has an installed base of over 4,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer, M/F/H/V. Visit Candela on the Web at www.clzr.com.

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future which are, therefore, inherently subject to risks and uncertainties. Candela's actual results could differ materially from those anticipated in Candela's forward-looking statements based on various factors, including without limitation: cancellation or deferral of customer orders, total dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, or changes in economic conditions. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Form 10-K (or any amendment thereto) for the year ended July 1, 2000, and subsequent Forms 10-Q. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstance on which any such statement is based.